Increases speed to market for drug developers working on nucleic acid therapeutics Reduces complexity for customers Strengthens portfolio of system solutions ESSEN, DE – Evonik is partnering with ST Pharm,… Read More
Proceeds will accelerate development of functional cures for people living with serious diseases and deepen Aspect’s full-stack tissue therapeutic platform VANCOUVER, BC – Aspect Biosystems, a biotechnology company pioneering the… Read More
Lithuania continues its rise as a life sciences powerhouse in Europe. From impressive GDP contributions to groundbreaking infrastructure projects, the country is setting the pace for innovation and growth in… Read More
Median overall survival improvement expected to exceed one year First and only regimen with a survival benefit over current standard of care in first-line treatment of EGFR-mutated lung cancer RARITAN,… Read More
VANCOUVER, BC — Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company focused on the development of new cancer therapies based on novel DNA-damage response technologies, announces the successful synthesis of novel small-molecule… Read More
